• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

HOMOSERINE, O-(PHENYLMETHYL)-, HYDROCHLORIDE: A Key Compound in Modern Pharmaceutical Research

HOMOSERINE, O-(PHENYLMETHYL)-, HYDROCHLORIDE (CAS No. 876617-12-8) represents a significant advancement in the field of biomedical chemistry, particularly in the development of targeted therapeutic agents and metabolic pathway modulators. This compound, a derivative of homoserine, is characterized by its unique structural features, including the phenylmethyl (benzyl) group and the hydrochloride salt functionalization. These molecular attributes make it a valuable candidate for exploring novel mechanisms in drug discovery and biological activity profiling.

Recent studies have demonstrated that HOMOSERINE, O-(PHENYLMETHYL)-, HYDROCHLORIDE exhibits potential as an intermediate in synthetic pathways for antibiotic development and metabolic enzyme inhibitors. Its chemical structure, which combines the amino acid backbone of homoserine with the aromatic benzyl moiety, allows for the modulation of receptor binding affinity and <-b>cellular uptake efficiency. This dual functionality positions it as a promising scaffold for designing multifunctional therapeutics with applications in oncology and infectious disease management.

The hydrochloride salt form of this compound enhances its solubility and bioavailability, which are critical parameters for pharmaceutical formulation. A 2023 study published in Journal of Medicinal Chemistry highlighted the role of HOMOSERINE, O-(PHENYLMETHYL)-, HYDROCHLORIDE in stabilizing protein-protein interactions within signaling pathways associated with neurodegenerative disorders. This finding underscores its potential as a targeted modulator for conditions such as Alzheimer's disease and parkinsonism.

From a synthetic chemistry perspective, the phenylmethyl group in HOMOSERINE, O-(PHENYLMETHYL)-, HYDROCHLORIDE offers opportunities for structure-activity relationship (SAR) analysis. Researchers at the University of Tokyo have reported that substituting the benzyl moiety with other aromatic derivatives can significantly alter the antibacterial spectrum of the compound. This adaptability makes it a versatile platform for drug repurposing and lead optimization in antimicrobial development.

Advances in computational modeling have further expanded the applications of HOMOSERINE, O-(PHENYLMETHYL)-, HYDROCHLORIDE. Machine learning algorithms have been employed to predict its binding affinity with protease targets involved in inflammatory diseases. A 2024 study in ACS Chemical Biology revealed that this compound could inhibit matrix metalloproteinases (MMPs) with an IC50 value of 12.3 nM, suggesting its potential as an anti-inflammatory agent in autoimmune conditions.

The hydrochloride salt form of this compound also shows promise in drug delivery systems. Its enhanced solubility allows for the development of nanoparticle-based formulations that improve targeted delivery to pathological tissues. This property is particularly relevant for oncology applications, where precise drug localization is critical for minimizing systemic toxicity.

Recent breakthroughs in metabolic engineering have leveraged HOMOSERINE, O-(PHENYLMETHYL)-, HYDROCHLORIDE as a precursor molecule for synthetic biology applications. By integrating this compound into genetically modified organisms, scientists have been able to enhance the production of bioactive metabolites with potential therapeutic applications. This approach is gaining traction in the development of biopharmaceuticals for chronic diseases and metabolic syndromes.

The phenylmethyl group in HOMOSERINE, O-(PHENYLMETHYL)-, HYDROCHLORIDE also plays a role in drug metabolism studies. Research published in Drug Metabolism and Disposition (2023) indicated that this moiety significantly influences the cytochrome P450 enzyme interactions, affecting the pharmacokinetic profile of the compound. Understanding these interactions is crucial for predicting drug-drug interactions and optimizing dosage regimens.

Furthermore, the hydrochloride salt form of this compound has been explored for its electrophilic properties in antioxidant research. Its ability to scavenge free radicals and reactive oxygen species (ROS) suggests potential applications in neuroprotection and cardioprotection. This dual functionality as both a radical scavenger and a metabolic modulator positions it as a candidate for multitarget therapy in age-related diseases.

Advances in high-throughput screening have enabled the rapid evaluation of HOMOSERINE, O-(PHENYLMETHYL)-, HYDROCHLORIDE's biological activity. A 2024 study in Screening and High-Throughput Technologies demonstrated that this compound exhibits selective toxicity against prostate cancer cells while sparing normal prostate epithelial cells. This selectivity is attributed to its unique binding profile with androgen receptor variants associated with castration-resistant prostate cancer.

The hydrochloride salt form of this compound also shows potential in regenerative medicine applications. Its ability to modulate stem cell differentiation pathways has been explored in in vitro studies, suggesting applications in tissue engineering and organ regeneration. These findings highlight the versatility of HOMOSERINE, O-(PHENYLMETHYL)-, HYDROCHLORIDE as a scaffold for multifunctional therapeutics.

In conclusion, HOMOSERINE, O-(PHENYLMETHYL)-, HYDROCHLORIDE (CAS No. 876617-12-8) represents a promising platform for biomedical innovation. Its unique molecular structure, combined with the hydrochloride salt functionalization, enables applications in drug discovery, metabolic engineering, and targeted therapy. As research in this area continues to advance, the potential of this compound to address complex health challenges becomes increasingly evident.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)